| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1776108A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 04/25/2007 | EP1615652B1 Treatment of severe acute respiratory syndrome (sars) |
| 04/25/2007 | EP1537100B1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 04/25/2007 | EP1430133B1 A soluble toll-like receptor |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1100780B1 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZ[F]INDOLES, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953745A Combinations of glycopyrrolate and beta2 adrenoceptor agonists |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1951494A Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof |
| 04/25/2007 | CN1951490A Lung beneficial preparation with astragalus root and scutellaria root for treating chronic pulmonary heart disease and preparation method thereof |
| 04/25/2007 | CN1951471A A liquid capsule of 'She Dan Chuan Bei' and preparation method thereof |
| 04/25/2007 | CN1951461A Orally administered Chinese medicine for treating infant asthma with profuse sputum |
| 04/25/2007 | CN1951458A Instant acting medicament for treating rhinitis |
| 04/25/2007 | CN1951454A Antiinflammation ointment plaster for treating tonsillitis |
| 04/25/2007 | CN1951450A Orally administered Chinese medicine for treating asthma complicated with fever |
| 04/25/2007 | CN1951438A Medicinal food for treating senile bronchial asthma |
| 04/25/2007 | CN1951437A Orally administered Chinese medicine for treating asthma |
| 04/25/2007 | CN1951433A Chinese medicinal composition for treating rhinitis and preparation process thereof |
| 04/25/2007 | CN1951419A Capsule for treating cough, asthma and pharyngitis |
| 04/25/2007 | CN1951412A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951411A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951387A Medicinal combinations composed by Imipenem, Cilastatin and three kinds of sputum removing medicament |
| 04/25/2007 | CN1951386A Medicinal combinations composed by meropenem with three kinds of sputum removing medicament respectively |
| 04/25/2007 | CN1951379A Medicinal combination composed by Fudosteine with nine kinds of antiseptic medicament respectively |
| 04/25/2007 | CN1951362A Tooth cleaning foam and preparation method thereof |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/25/2007 | CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1311838C Chinese medicine preparation for relieving cough, removing phlegm, relieving asthma and anti-inflammation |
| 04/25/2007 | CN1311816C Gum of ambroxol hydrochloride and preparation thereof |
| 04/25/2007 | CN1311814C Rabdosia dripping pill and its preparing method |
| 04/25/2007 | CN1311808C Process for preparing granular preparation for treating pharyngeal disease and method for controlling quality |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208518 antiinflammatory agents; asthma; 2-hydroxy-3-(4-hydroxy-5-methyl-2-oxo-2H-chromene-3-yl)-9-methyl-2,3-dihydro-4H-furo[3,2-c]chromene-4-one; from 4-Hydroxycoumarin and glyoxal |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208162 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | US7208141 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
| 04/24/2007 | CA2301711C Lipid-containing compositions and uses thereof |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2171934C Endothelin receptor antagonists |
| 04/19/2007 | WO2007043939A1 Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a |
| 04/19/2007 | WO2007043938A1 NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043568A1 S1p3 receptor antagonist |
| 04/19/2007 | WO2007042816A1 Benzoxazoles useful in the treatment of inflammation |
| 04/19/2007 | WO2007042815A1 Compounds containing more than one human neutrophil elastase inhibiting moiety for use in the treatment of respiratory diseases |
| 04/19/2007 | WO2007042811A1 Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease |
| 04/19/2007 | WO2007042467A1 Novel pharmaceutical combinations for the treatment of respiratory disorders |
| 04/19/2007 | WO2007042321A2 Kinase inhibitors |
| 04/19/2007 | WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 04/19/2007 | WO2006134021A3 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
| 04/19/2007 | WO2006120176A3 Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative |
| 04/19/2007 | WO2006088925A3 Use of il17-f in diagnosis and therapy of airway inflammation |
| 04/19/2007 | WO2006077471A3 Combining therapies targeting multiple toll-like receptors and use thereof |
| 04/19/2007 | WO2006055532A3 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 04/19/2007 | WO2006041808A8 Tafi inhibitors and their use to treat pulmonary fibrosis |
| 04/19/2007 | US20070088087 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070087969 Wound healing and treatment of fibrosis |
| 04/19/2007 | US20070087375 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710 |
| 04/19/2007 | US20070086956 Method for accelerating the rate of mucociliary clearance |
| 04/19/2007 | CA2626011A1 S1p3 receptor antagonist |
| 04/19/2007 | CA2625218A1 Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease |
| 04/19/2007 | CA2624683A1 Modulators of atp-binding cassette transporters |
| 04/19/2007 | CA2624584A1 Novel pharmaceutical combinations for the treatment of respiratory disorders |
| 04/19/2007 | CA2623500A1 Kinase inhibitors |
| 04/19/2007 | CA2620899A1 Benzoxazoles useful in the treatment of inflammation |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1775297A2 Adenosine receptor antagonists and methods of making and using the same |
| 04/18/2007 | EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/18/2007 | EP1773816A2 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773374A1 An agent comprising fgf2 as an effective ingredient for treatment or prevention of asthma and chronic obstructive pulmonary disease |
| 04/18/2007 | EP1773361A1 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773325A1 Methods of using albuterol and calcium activated potassium channel openers |
| 04/18/2007 | EP1773319A1 Combinations of statins with bronchodilators |
| 04/18/2007 | EP1633369B1 Process to minimize loss through adhesion to equipment surfaces |
| 04/18/2007 | EP1537109B1 Novel benzonaphthyridines |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1453545B1 Water-soluble polymer conjugates of retinoic acid |
| 04/18/2007 | EP1442032B1 Heterocyclic retinoid compounds |